FAK
FAK (focal adhesion kinase), also known as PTK2, is a focal adhesion-associated protein kinase involved in cellular adhesion and spreading processes.
Products for FAK
- Cat.No. Product Name Information
-
GC68626
Adhesamine
Adhesamine is a dumbbell-shaped molecule that can activate the MAPK/FAK pathway. Adhesamine promotes adhesion and growth of mammalian cells. Adhesamine accelerates differentiation of primary cultured mouse hippocampal neurons and improves survival rate.
-
GC72932
Adhesamine diTFA
Adhesamine diTFA is a dumbbell-shaped molecule that activates the MAPK/FAK pathway.
-
GC64015
AMP-945
AMP-945
AMP-945 is an inhibitor of the enzyme focal adhesion kinase (FAK). -
GC64377
Batatasin III
Batatasin III, a stilbenoid, inhibits cancer migration and invasion by suppressing epithelial to mesenchymal transition (EMT) and FAK-AKT signals. Batatasin III has anti-cancer activities.
-
GC65457
BI-3663
BI-3663 is a highly selective PTK2/FAK PROTAC (DC50=30 nM), with Cereblon ligands to hijack E3 ligases for PTK2 degradation. BI-3663 inhibits PTK2 with an IC50 of 18 nM. BI-3663 is a PROTAC that composes of BI-4464 linked to Pomalidomide with a linker. Anti-cancer activity.
-
GC34488
BI-4464
BI-4464 is a highly selective ATP competitive inhibitor of PTK2/FAK, with an IC50 of 17 nM. A PTK2 ligand for PROTAC.
-
GC65886
BI-853520
IN-10018
BI 853520 (IN-10018) is an orally active and potent focal adhesion kinase (FAK) inhibitor (recombinant FAK IC50=1nM). BI 853520 shows anti-proliferative activity against cancer cells. -
GC15273
CEP-37440
FAK/ALK inhibitor,potent and selective
-
GC32979
Chloropyramine hydrochloride
Chloropyramine hydrochloride is a histamine receptor H1 antagonist which can also inhibit the biochemical function of VEGFR-3 and FAK.
-
GC35728
Conteltinib
CT-707
Conteltinib (CT-707) is a multi-kinase inhibitor targeting FAK, ALK, and Pyk2. Conteltinib exerts significant inhibitory effect on FAK with an IC50 of 1.6 nM. -
GC16813
Defactinib
PF-04554878, VS-6063
FAK phosphorylation inhibitor
-
GC35827
Defactinib hydrochloride
VS-6063 hydrochloride; PF 04554878 hydrochloride
A novel FAK inhibitor -
GC12174
FAK Inhibitor 14
Focal Adhesion Kinase Inhibitor 14, NSC 667249, NSC 677249, Y15
FAK Inhibitor 14 is a potent and specific inhibitor of focal adhesion kinase (FAK) that inhibits its autophosphorylation activity, decreases the viability of cancer cells, and blocks tumor growth. -
GC36025
FAK inhibitor 2
FAK inhibitor 2 is a potent focal adhesion kinase (FAK) inhibitor with an IC50 ?of 0.07?nM, with antitumor and anti-angiogenesis activities.
-
GC73575
FAK-IN-14
FAK-IN-14 (compound 8d) is a focal adhesion kinase(FAK) inhibitor with an IC50 value of 0.2438 nM.
-
GC68030
FAK-IN-7
-
GC38437
Fangchinoline
7-O-Demethyltetrandrine, Hanfangchin B, NSC 77036
An alkaloid with diverse biological activities -
GC73149
FLT3-IN-17
FLT3-IN-17 inhibits CYPs and FLT3 mutants activity (IC50s: <0.5 nM for D835Y).
-
GC64888
GSK215
GSK215 is a potent and selective PROTAC focal adhesion kinase (FAK) degrader with a pDC50 of 8.4. GSK215 is designed by a binder for the VHL E3 ligase and the FAK inhibitor VS-4718. GSK215 induces rapid and prolonged FAK degradation, giving a long-lasting effect on FAK levels and a marked pharmacokinetic/pharmacodynamics (PK/PD) disconnect.
-
GC19179
GSK2256098
GSK2256098 is a selective FAK kinase inhibitor, which inhibits growth and survival of pancreatic ductal adenocarcinoma cells.
-
GC13410
Masitinib (AB1010)
AB-1010, Masican, Masiviera
Masitinib (AB1010) (AB1010) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib (AB1010) (AB1010) has anti-proliferative, pro-apoptotic activity and low toxicity. -
GC33045
NAMI-A
NAMI-A is a ruthenium-based drug characterised by the selective activity against tumour metastases, inhibits the adhesion and migration.
-
GC44605
Petunidin (chloride)
Petunidol
Petunidin is an O-methylated anthocyanidin derived from delphinidin that imparts blue-red pigments to flowers, fruits, and red wine.
-
GC14767
PF-00562271
PF-562271;PF00562271;PF62271
PF-562271 (VS-6062) besylate is a potent ATP-competitive, reversible inhibitor of FAK and Pyk2 kinase, with an IC50 of 1.5 nM and 13 nM, respectively. -
GC14407
PF-431396
Pyk2 and FAK inhibitor
-
GC15380
PF-562271
PF562271;PF 562271
PF-562271 is a potent small-molecule inhibitor of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2) with a IC50 of 1.5 and 14nmol/L, respectively. -
GC10810
PF-562271 HCl
PF562271 HCl;PF 562271 HCl
PF-562271 (VS-6062) hydrochloride is a potent, ATP-competitive and reversible FAK and Pyk2 kinase inhibitor with IC50s of 1.5 nM and 13 nM, respectively. -
GC11107
PF-573228
FAK Inhibitor II, Focal Adhesion Kinase Inhibitor II
ATP-competitive FAK inhibitor -
GC15164
PND-1186
SR 2516, VS-4718
A potent FAK inhibitor -
GC62111
PND-1186 hydrochloride
VS-4718 hydrochloride; SR-2516 hydrochloride
PND-1186 hydrochloride (VS-4718 hydrochloride) is a potent, highly-specific and reversible inhibitor of FAK with an IC50 of 1.5 nM. PND-1186 hydrochloride selectively promotes tumor cell apoptosis. -
GC36985
PROTAC FAK degrader 1
PROTAC FAK degrader 1 is a selective and potent von Hippel-Lindau-based focal adhesion kinase (FAK) degrader with an IC50 of 6.5 nM, DC50 of 3 nM.
-
GC73424
PRT062607 acetate
P505-15 acetate; PRT-2607 acetate; BIIB-057 acetate
PRT062607 (P505-15) acetate is an orally available Syk inhibitor (IC50: 1 nM) that inhibits inflammation and induction Apoptosis. -
GC74116
Pyk2-IN-2
Pyk2-IN-2 (compound 13j) is an inhibitor of Pyk2 with an IC50 of FAK kinase of 0.608 μM.
-
GC17500
SU6656
Src tyrosine kinases inhibitor
-
GC16821
TAE226(NVP-TAE226)
TAE 226;TAE-226
TAE226(NVP-TAE226) (TAE226) is a potent and ATP-competitive dual FAK and IGF-1R inhibitor with IC50s of 5.5 nM and 140 nM, respectively. -
GC68463
ULK1-IN-2
-
GC14489
Y 11
FAK Inhibitor 10
focal adhesion kinase (FAK) inhibitor
-
GC64992
YH-306
YH-306 is an antitumor agent. YH-306 suppresses colorectal tumour growth and metastasis via FAK pathway. YH-306 significantly inhibits the migration and invasion of colorectal cancer cells. YH-306 potently suppresses uninhibited proliferation and induces cell apoptosis. YH-306 suppresses the activation of FAK, c-Src, paxillin, and PI3K, Rac1 and the expression of MMP2 and MMP9. YH-306 also inhibita actin-related protein (Arp2/3) complex-mediated actin polymerization.
-
GC73041
ZINC40099027
ZINC40099027 is a FAK activator.